Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study.
about
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?State of the art treatments for cannabis dependenceCannabis and psychosis: what causes what?Substance use in clinical high risk for psychosis: a review of the literatureGone to Pot - A Review of the Association between Cannabis and PsychosisCannabis and psychosis: NeurobiologyMismatch Negativity and P50 Sensory Gating in Abstinent Former Cannabis Users.The evolution of cognitive-behavioral therapy for psychosisPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisAssociations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and ChildrenDying to be famous: retrospective cohort study of rock and pop star mortality and its association with adverse childhood experiencesCannabis and Canadian youth: evidence, not ideologyMultimorbidity patterns in primary care: interactions among chronic diseases using factor analysis.Blurred boundaries: the therapeutics and politics of medical marijuana.Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts.Can cannabis be considered a substitute medication for alcohol?Cannabis controversies: how genetics can inform the study of comorbidityWhat has research over the past two decades revealed about the adverse health effects of recreational cannabis use?Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendationsImpact of Cannabis Use on the Development of Psychotic DisordersMultimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis useCannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice populationStigma among California's Medical Marijuana Patients.Cannabinoid modulation of functional connectivity within regions processing attentional salience.Developing the Moti-4 intervention, assessing its feasibility and pilot testing its effectiveness.No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder.Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis.Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.A dimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults.Psychopathology in Substance Use Disorder Patients with and without Substance-Induced PsychosisExposure to environmental factors increases connectivity between symptom domains in the psychopathology network.Alcohol and drug use disorders among adults in emergency department settings in the United States.Chronic adolescent marijuana use as a risk factor for physical and mental health problems in young adult men.Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcomeCannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors.Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend.Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthoodAssociation of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational studyCannabinoids: is there a potential treatment role in epilepsy?
P2860
Q21129107-E4E1F75E-4685-48D4-8E08-C91873BBE5A4Q24607810-15DC10B0-43AF-41DB-AF0D-BC8EBF25BD08Q24633141-CB3FC5EC-286D-42D1-B3EB-1C998C938B06Q26859349-5EF1A1DC-4F1E-4846-8E86-2CB6853B63FFQ26865311-855560D8-BE19-4096-ABBD-B78A1E7215DEQ27024404-707156F1-4E07-4CD8-A1C6-EA2FD5AEED10Q27312326-498C167A-0060-4419-9297-FF4E454D28B9Q28082402-7F3053AB-0D76-4ABB-8E9F-B4D9DEE15E47Q28085455-E3767B8F-E498-4B5F-9250-A97A9662EECEQ28650412-FFED99DC-3A63-4BD1-8CA6-655C1407EAE4Q28710154-12CCEB75-D993-4912-932D-A37FC76C637CQ34173024-5E587183-4897-454F-9C9B-3AEAE83D57CDQ34185797-7EE9C7D8-8D26-471E-8A0B-724228EF053EQ34251969-290692AA-2989-4C40-A3CD-23BBE036FE8CQ34311721-CD2EEB44-634E-4261-B74F-3D0400C9D181Q34381806-FC89473C-9E06-4CD1-BC45-2EEA6C46C5D8Q34396537-617C8086-A1EB-4A1A-8D2B-0EF189403CE1Q34398604-77230A01-8B78-4AA5-A4E0-E8B8B40461F9Q34442084-DCEB341B-3DB8-4E2E-B0F4-FA3387DDB14BQ34453438-ED992613-E187-45A7-A938-8F0FE2FE3922Q34668606-83640B83-6FE9-4BEB-8F8D-12462CE7964EQ35019147-AB7F0F88-7DA6-4918-B5C3-3E69200B32C5Q35075988-BF3A13F9-B01E-46DC-B601-51C63F767783Q35124951-961C645C-1245-4BC2-AC9F-1B4C24CB8B94Q35420974-71DF2435-64C8-46DB-B096-02B0EF969998Q35635633-642C2D01-93FF-48CC-8632-CF3F837C7863Q35715158-97954923-0F9E-42F0-85CD-B9E9C5153211Q35836722-2F042E15-B1EA-4745-90CE-FE5A61A4FC2FQ35955940-5CB69C1F-F330-4158-8322-5ECE40CC91C3Q36016601-552F6CD2-5040-4AA1-9B97-C7532EB73BD6Q36055956-370563BC-E5D9-4525-8D8E-FEB95ABE145CQ36071272-06DCB8D1-6855-455F-816D-75213668B57EQ36071857-7DE3E1DD-2CA2-41FC-9834-6DA5CF7B163CQ36101442-8F6097A0-8CEB-4647-9091-00E8BF2D664CQ36281966-B0463441-29D2-4316-93F0-FA58CC71A16DQ36582466-79F3765D-55A5-48E6-B477-46814A8A4AF6Q36620997-55015520-3F9F-45C4-94AD-77AD8860F42FQ36665743-B2F02217-C2B5-4F07-BB23-A621E37F8F53Q36670457-0CBA7056-C22A-45D1-B2D3-F337DDEEF44CQ36837343-E286B9D1-17BD-41BA-90DD-2554CD8B3297
P2860
Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Continued cannabis use and ris ...... 0 year follow-up cohort study.
@ast
Continued cannabis use and ris ...... 0 year follow-up cohort study.
@en
Continued cannabis use and ris ...... 0 year follow-up cohort study.
@nl
type
label
Continued cannabis use and ris ...... 0 year follow-up cohort study.
@ast
Continued cannabis use and ris ...... 0 year follow-up cohort study.
@en
Continued cannabis use and ris ...... 0 year follow-up cohort study.
@nl
prefLabel
Continued cannabis use and ris ...... 0 year follow-up cohort study.
@ast
Continued cannabis use and ris ...... 0 year follow-up cohort study.
@en
Continued cannabis use and ris ...... 0 year follow-up cohort study.
@nl
P2093
P2860
P356
P1433
P1476
Continued cannabis use and ris ...... 0 year follow-up cohort study.
@en
P2093
Cécile Henquet
Michael Höfler
Rebecca Kuepper
Roselind Lieb
P2860
P356
10.1136/BMJ.D738
P407
P577
2011-03-01T00:00:00Z